Rebecka Hellsten

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Prostate Cancer

Radical Prostatectomy

Replacement Therapy

Pseudomonas Aeruginosa

Top Venues

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Kristina Witt, Susan Evans-Axelsson, Andreas Lundqvist, Martin Johansson, Anders Bjartell, Rebecka Hellsten
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer. Cancer immunology, immunotherapy : CII 70 (11) (2021)
Rebecka Hellsten, Lisa Lilljebjörn, Martin Johansson, Karin Leandersson, Anders Bjartell
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors. The Prostate 79 (14) (2019)
Agnieszka Krzyzanowska, Nicholas Don-Doncow, Felicia Elena Marginean, Alexander Gaber, R William Watson, Rebecka Hellsten, Anders Bjartell
Expression of tSTAT3, pSTAT3727 , and pSTAT3 705 in the epithelial cells of hormone-naïve prostate cancer. The Prostate 79 (7) (2019)